Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CNC · against 80 other Healthcare companies of similar size
Ranked #75 of 81 · scores higher than 0% of peers
Bars: peers in each 10-point band of the valuation score7 peers with a valuation score of 0–9, including CNC · Click a bar to see the companies
Mainly because of its earnings yield, which is weaker than most Healthcare peers.
| Metric | CNC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 77 reported | -15.5% | 2.9% | 0% | 30% | |
| EBITDA yieldHigher is better · 82 reported | 20.5% | 5.3% | 100% | 50% | |
| Free cash flow yieldHigher is better · 56 reported | 26.9% | 3.9% | 100% | 20% | |
| Book yieldHigher is better · 76 reported | 67.7% | 20.1% | 93% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.5B USD | 95 | 60 | |
| 2 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 3 | 2.57T JPY (≈$17.5B) | 88 | 62 | |
| 4 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 5 | 45.9B USD | 84 | 61 | |
| 72 | 138.4B HKD (≈$17.7B) | 39 | 70 | |
| 72 | 2.67T INR (≈$32.1B) | 39 | 68 | |
| 74 | 45.2B USD | 38 | 46 | |
| 75 | 21.8B USD | 8 | 32 | |
| 75 | 33.3B USD | 8 | 24 | |
| 75 | 23.5B USD | 8 | 27 | |
| 75 | 22.8B USD | 8 | 38 | |
| 75 | 56.0B USD | 8 | 39 | |
| 75 | 26.0B USD | 8 | 28 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score